StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
219550.KQ$1413.00-6.20%
Fair $1413.00+0.0%

219550.KQ

Jaanh Cosmetics,Inc.

Consumer Defensive / Household & Personal ProductsKOSDAQ

$1413.00

-99.00 (-6.20%)

Fairly Valued+0.0%Fair Value $1413.00Fund rank 27/100 · Data gapFallback financials|
SA 21/D
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 22%

FCF escenarios

weak_data · normalized FCF $-6.5B · quality 60.7/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 37/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

21/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -1.4%, below the 5% threshold
Thesis & Journal · 219550.KQLocal privado en este navegador · Jaanh Cosmetics,Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$44.2B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-135.6%

↓

Gross Margin

41.7%

↑

Debt/Equity

1.04

↑
52-Week Range$1413
$772$2580

TradingView lightweight chart

219550.KQ price, volumen y niveles de valoración

Último $1,499Periodo -96.5%
Fair value: $1,413

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+29.2%

FCF CAGR

—

FCF margin

-12.6%

FCF / Net income

0.41x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $44.90B · net income $-13.72B · FCF $-5.67B

2022-FY → 2025-FY

Gross margin

41.7%-3.5% pts

Operating margin

4.7%+2.2% pts

Net margin

-30.6%-34.9% pts

FCF margin

-12.6%+17.6% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$44.90B$44.90B$37.38B$28.46B$20.84B
Net Income$-13.72B$-13.72B$-59.12B$-19.07B$901.6M
EBITDA$-10.28B$-10.28B$-54.78B$-14.50B$1.44B
EPS-125.00-125.00-824.00-1516.00120.00
Gross Margin41.7%41.7%42.1%38.6%45.2%
Operating Margin4.7%4.7%-0.1%-11.7%2.5%
Net Margin-30.6%-30.6%-158.1%-67.0%4.3%
Balance Sheet
Debt/Equity1.041.040.900.790.00
Current Ratio4.594.59———
Cash Flow
Free Cash Flow$-5.67B$-5.67B$-6.48B$-8.31B$-6.30B
Returns
ROE-135.6%-135.6%-590.2%-48.9%2.0%
Valuation
P/E————39.50
EV/EBITDA————23.59
P/B4.374.373.961.120.80
Growth & Yield
Revenue Growth20.1%20.1%31.3%36.6%—
EPS Growth84.8%84.8%45.6%-1363.3%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -35.1%

Total return

-35.1%

Start / end P/E

n/dx → n/dx

EPS bridge

-824.00 → -125.00

Residual

-35.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-35.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.